Clinical Trial Update: Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost

View source ↗

Summary

This clinical trial update evaluates longitudinal outcomes of patients with Group 3 pulmonary hypertension treated with iloprost. The study is currently not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Due to Lung Diseases

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pulmonary Hypertension Due to Lung Diseases | Status: NOT_YET_RECRUITING